"Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030"
North America held the largest market share (40.5%)

The global lab automation market, valued at USD 5.97 billion in 2024, is projected to grow from USD 6.36 billion in 2025 to USD 9.01 billion by 2030, expanding at a CAGR of 7.2%. This strong growth trajectory underscores the industry’s pivotal transformation toward intelligent, data-driven, and high-throughput laboratory operations.

The surge in demand for high-throughput screening (HTS)—particularly in drug discovery and clinical diagnostics—is one of the core forces driving this evolution. Automation minimizes human intervention, improves reproducibility, and accelerates time-to-results, making it indispensable for both research and clinical workflows.

Why Lab Automation is Gaining Momentum

1. High-Throughput Screening: The Catalyst of Efficiency

In pharmaceutical and biotech research, high-throughput screening enables rapid testing of thousands of compounds, identifying potential drug candidates faster and more accurately than traditional methods. Automated systems facilitate this by integrating robotics, advanced imaging, and real-time data analytics, ensuring precision and consistency across experiments.

2. Bridging the Skilled Labor Gap

The ongoing shortage of skilled laboratory personnel has amplified the adoption of automated systems that require minimal human supervision. Automation not only reduces labor costs but also minimizes manual errors and enhances safety and productivity in complex workflows.

3. Technological Advancements in AI and Robotics

Breakthroughs in robotics, artificial intelligence (AI), and machine learning (ML) are revolutionizing laboratory processes—from sample handling and image analysis to predictive analytics. These technologies are enabling laboratories to optimize throughput, streamline operations, and make data-backed decisions with confidence.

Regional Spotlight: North America Leads the Way

North America, accounting for 40.5% of the global market share in 2024, remains the epicenter of innovation in lab automation. The region’s strong R&D ecosystem, supported by extensive funding from both public and private sectors, has fostered a wave of technological breakthroughs.

From AI-driven molecular diagnostics to automated testing systems, laboratories across the US and Canada are embracing smart automation to enhance accuracy, scalability, and regulatory compliance. This trend is further supported by the presence of key market players and government-backed healthcare innovation programs.

Key Market Dynamics

Driver: Automation Accelerating Drug Discovery

Automation is transforming drug discovery pipelines by simplifying complex workflows and expediting research timelines. High-throughput screening platforms powered by automation reduce human error, increase reproducibility, and allow researchers to analyze large data sets effectively.

Innovators such as ArrayJet (UK) and SCIEX (US) are leveraging cutting-edge technologies like bioprinting and Acoustic Ejection Mass Spectrometry (AEMS) to redefine precision in molecular analysis. Additionally, 3D cell models and microfluidics are improving drug safety and efficacy assessment—key steps toward next-generation drug discovery automation.

Restraint: Slow Adoption in Developing Economies

Despite its advantages, lab automation adoption remains limited in developing countries due to high capital and maintenance costs. In some cases, annual service and software update fees account for 20–30% of total investment, creating financial barriers for small and mid-sized laboratories.

The lack of trained personnel and uncertainty regarding long-term ROI further dampen adoption. For sustainable growth, these markets need cost-efficient, scalable solutions and stronger policy support for technology integration.

Opportunity: Expanding Pharma and Biotech Industries in Asia

The rapid expansion of pharmaceutical and biotechnology sectors in India and China presents major growth opportunities for lab automation providers.

  • India accounts for 50% of global vaccine production, 40% of US generic drug consumption, and 25% of UK medicine use, with a thriving biotech ecosystem of over 5,000 firms.
  • China’s “Made in China 2025” initiative is propelling domestic biotech innovation, focusing on self-reliance and high-end manufacturing.

As these industries scale, automation becomes critical for ensuring efficiency, regulatory compliance, and faster innovation cycles. Vendors offering affordable, adaptable automation systems stand to capture significant market share in these high-growth regions.

Challenge: System Integration Complexities

A key challenge for laboratories adopting automation lies in system integration. Legacy equipment, diverse software platforms, and non-standardized protocols often create compatibility issues. This lack of interoperability leads to longer implementation times, calibration challenges, and increased costs.

Market Ecosystem and Segmentation Insights

The lab automation market encompasses a broad range of products—from automated workstations and robotic systems to software platforms and storage solutions. These technologies find applications in drug discovery, genomics, proteomics, microbiology, and diagnostics.

1. Automated Workstations Lead the Market

In 2024, automated workstations dominated the market due to their ability to enhance precision and productivity. These systems automate critical laboratory operations such as liquid handling, sample preparation, and data management.

An example is Tecan Group’s Fluent Liquid Handler (Switzerland), equipped with multi-arm robotics for high-precision pipetting and object handling—significantly improving efficiency and accuracy in laboratory workflows.

2. Drug Discovery Dominates Application Segment

The drug discovery segment held the largest market share and is expected to grow further. Automation enables faster compound screening, assay development, and lead optimization—key to developing treatments for oncology, infectious diseases, and neurological disorders.

Platforms like Automata’s LINQ (UK) are empowering researchers to execute complex assays and tissue cultures autonomously, marking a major step forward in laboratory efficiency.

3. Hospitals and Diagnostic Laboratories as Key End Users

Hospitals and diagnostic labs accounted for the largest end-user share in 2024, reflecting the demand for rapid, high-accuracy testing. Automation in these environments ensures streamlined workflows, reduced turnaround time, and improved patient outcomes, particularly in high-volume diagnostic testing.

The Road Ahead: Toward Intelligent, Integrated Laboratories

The future of lab automation lies in smart integration, predictive analytics, and AI-driven decision-making. As laboratories transition from manual to fully connected ecosystems, automation will be the cornerstone of precision medicine, data integrity, and operational excellence.

With growing investments in R&D, strategic partnerships, and advancements in robotics and AI, the global lab automation market is set to redefine the future of scientific discovery and clinical diagnostics.

Key Takeaways

  • Market size: USD 9.01 billion by 2030 at a CAGR of 7.2%
  • Primary driver: High-throughput screening and AI-enabled automation
  • Leading region: North America (40.5% share in 2024)
  • Top segment: Automated workstations & drug discovery applications
  • Emerging opportunities: Expanding pharma and biotech industries in Asia

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html

 

Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Lab Automation Market Growth, Drivers, and Opportunities | MarketsandMarkets™

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]